Baby formula bandit busted for forging prescriptions, hawking formula to desperate moms
Washington Times, The (DC)
A New York man has pleaded guilty to fraudulently obtaining specialty baby formula that he then sold on the black market.
From March 2019 through October 2022, Vladislav Kotlyar, 43, submitted forged medical documents and prescriptions for specialty baby formula.
Kotlyar and others also filed for $1.9 million in reimbursement from insurance providers. This coincided with a national shortage of baby formula resulting from an early 2022 Cronobacter sakazakii outbreak that temporarily shuttered a Michigan baby formula plant.
Kotlyar, who lived on Staten Island, obtained the original documents and prescriptions for infants who required a distinct formula for medical reasons. He then forged new documents and prescriptions and ordered additional baby formula.
“I obtained baby formula fraudulently from the insurance companies using the mail, through scripts that were forged … just the signature was forged by myself,” Kotlyar told Judge William Kuntz, according to the New York Daily News.
Kotlyar also made up issues with the shipments, such as damage to the shipment or the formula being incorrect, so the formula providers would send him more, which he then sold.
Kotlyar forfeited around $1 million as part of his plea agreement to mail-fraud charges and will pay over $738,000 in restitution. On the count of mail fraud, Kotlyar faces up to 20 years in prison.
Berkshire Hathaway Specialty Insurance Names Ben Ruddlesdin Head of Professional Indemnity in London
Former Memphis Attorney Pleads Guilty to Wire Fraud Scheme
Advisor News
- Retirement is increasingly defined by a secure income stream
- Addressing the ‘menopause tax:’ A guide for advisors with female clients
- Alternative investments in 401(k)s: What advisors must know
- The modern advisor: Merging income, insurance, and investments
- Financial shocks, caregiving gaps and inflation pressures persist
More Advisor NewsAnnuity News
- Ameritas settles with Navy vet in lawsuit over disputed annuity sale
- NAIC annuity guidance updates divide insurance and advisory groups
- Retirement is increasingly defined by a secure income stream
- Beyond the S&P 500: The case for RILA diversification
- Globe Life Inc. (NYSE: GL) Making Surprising Moves in Monday Session
More Annuity NewsHealth/Employee Benefits News
- Data from Massachusetts General Hospital Provide New Insights into Managed Care (Utilization by high-cost, high-need Medicaid patients receiving social worker care coordination): Managed Care
- Study Results from Johns Hopkins University Bloomberg School of Public Health Provide New Insights into Managed Care and Specialty Pharmacy (Medicaid access to Most Favored Nation through the Pfizer agreement: The unanswered issues): Drugs and Therapies – Managed Care and Specialty Pharmacy
- Gabriel Bosslet: Stewardship over profit — why Indiana must rethink the Medicaid middle
- SHOP SMART FOR HEALTH INSURANCE
- CMS announces moratorium on new Medicare hospice/home health enrollment
More Health/Employee Benefits NewsLife Insurance News
- U-Haul Holding Company Schedules Fourth Quarter Fiscal Year End 2026 Financial Results Release and Investor Webcast
- New Empathy and LIMRA Research: The Overlooked Opportunity to Engage the Next Generation After an Insurance Payout
- Symetra Names Jeff Sealey Vice President, Stop Loss Captives
- 3 ways AI can help close the gap for women’s insurance coverage
- Best’s Market Segment Report: AM Best Revises Outlook on Italy’s Life Insurance Segment to Stable From Negative
More Life Insurance News